Display search results for ** instead (1276 products)

Showing 1-10 of 1276

02 Dec 2019  |  North America

Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024

Advancements in Continuous Manufacturing Technology, Necessary to Meet New Demand in the Orphan Drugs Segment and Personalized Medicine, Will Give a New Growth Vector to CMOs

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

USD 4,950.00
27 Nov 2019  |  North America

Analysis of the Hospital Asset Management Market, Forecast to 2023

Integration and Interoperability would Drive New Opportunities

A critical aspect of efficiency in healthcare organizations is asset management. Hospitals have thousands of assets to track and maintain, and failure of which results in increased waste and downtime, restricted patient flow, decreased quality of care, poor employee productivity, and financial losses. Hospitals are demanding more holistic solution...

USD 4,950.00
27 Nov 2019  |  North America

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...

USD 4,950.00
22 Nov 2019  |  North America

News Alert—US-China Tariff War Implication for Healthcare Industry

Better Understand the Timeline of the Tariff War and What Triggered the Hostilities

As the US-China Tariff War continues to escalate, the Transformational Healthcare Team at global research firm Frost & Sullivan has made available an insight analysis exploring the threats and opportunities for US businesses in China. The insight analysis also examines the timeline and causes of the tariff war and explores why medical technology (M...

USD 1,500.00
21 Nov 2019  |  North America

Medical Imaging Industry Quarterly Tracker, Q2 2019

Quarterly Edition of Trends in Medical Imaging and Informatics, Covering Competition, Policy, Regulatory, and Clinical Areas

The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors’ business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain tech...

USD 3,000.00
12 Nov 2019  |  North America

Neonatal Infant Care Device Market, Forecast to 2023

New-age Technology is Poised to Change Lifestyles—Can Conventional Products Survive?

The neonatal care market is at a juncture where the rate of innovation in devices is much lower, resulting in flat prices and mid-single digit market growth, largely driven by replacement sales. This is especially true for phototherapy units and some respiration assistance devices. However, with increasing demand to provide cost-effective care and ...

USD 3,000.00
06 Nov 2019  |  North America

Growth Opportunities in Human Microbiome Market, Forecast to 2023

Strategic Collaborations and Stakeholder Awareness Along with Clear Paths to Commercialization will Play a Key Role for Success in the Human Microbiome Market

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...

USD 4,950.00
04 Nov 2019  |  North America

Global Laboratory Products Purchasing Trends, 2019–2020

An End-user Perspective on Laboratory Spending Reveals Modest 2020 Budget Increases Following Healthier 2019 Spending

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2019 that centered around the state of their laboratories in 2019 and their expectations for 2020. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year...

USD 1,500.00
14 Oct 2019  |  North America

Innovations in Biomarker Analytics

Tracking the Market Landscape of Companies Striving to Derive Actionable Insights from the Data Deluge through the incorporation of Artificial Intelligence

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

USD 4,950.00
09 Oct 2019  |  North America

Frost Radar in the US Healthcare Data Analytics Market

A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines

US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...

USD 4,950.00

Showing 1-10 of 1276